CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
